Related Experiment Video
Updated: Feb 26, 2026

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
Protective effects of SOCS3 overexpression in high glucose‑induced lung epithelial cell injury through the JAK2/STAT3
Wei-Na Duan1, Zhong-Yuan Xia1, Min Liu1
1Department of Anesthesiology, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, P.R. China.
Abstract:
Previous studies have suggested that the Janus kinase (JAK)/signal transducers and activators of transcription (STAT) pathway is involved in hyperglycemia‑induced lung injury. The present study aimed to investigate the roles of suppressor of cytokine signaling3 (SOCS3) in the regulation of JAK2/STAT3 activation following high glucose (HG) treatment in A549 human pulmonary epithelial cells. Cell viability was evaluated using Cell Counting Kit-8 and lactate dehydrogenase assays. HG‑induced inflammatory injury in A549 cells was assessed through the evaluation of interleukin‑6 (IL‑6) and tumor necrosis factor‑α (TNF‑α) levels using ELISA. The protein expression levels of SOCS3, JAK2, STAT3, phosphorylated (p)‑JAK2 and p‑STAT3 were determined using western blot analysis. Cellular viability was significantly decreased, whereas IL‑6 and TNF‑α levels were significantly increased, following HG stimulation of A549 cells. In addition, the protein levels of SOCS3, p‑JAK2 and p‑STAT3 were significantly increased in HG‑treated cells. Treatment with the JAK2/STAT3 inhibitor tyrphostin AG490, or SOCS3 overexpression, appeared to prevent the HG‑induced alterations in protein expression. Furthermore, cellular viability was enhanced, whereas the levels of proinflammatory cytokines were suppressed. These finding suggested the involvement of the SOCS3/JAK2/STAT3 signaling pathway in HG‑induced responses in lung cells. Therefore, it may be hypothesized that the inhibition of the JAK2/STAT3 pathway through SOCS3 overexpression may prevent hyperglycemia‑induced lung injury, and may have therapeutic potential for the treatment of patients with diabetic lung injury.
Insights
High glucose levels harm lung cells by activating the Janus kinase (JAK)/signal transducer and activator of transcription (STAT) pathway. Suppressor of cytokine signaling 3 (SOCS3) may protect against this hyperglycemia-induced lung injury.
Area of Science:
- Pulmonary Medicine
- Cell Biology
- Molecular Signaling
Background:
- The Janus kinase (JAK)/signal transducer and activator of transcription (STAT) pathway is implicated in hyperglycemia-induced lung injury.
- Understanding the regulatory mechanisms of this pathway in lung epithelial cells is crucial for developing therapeutic strategies.
Purpose of the Study:
- To investigate the role of suppressor of cytokine signaling 3 (SOCS3) in regulating the JAK2/STAT3 pathway under high glucose conditions in A549 human pulmonary epithelial cells.
- To explore the potential of targeting the SOCS3/JAK2/STAT3 pathway for treating hyperglycemia-induced lung injury.
Main Methods:
- A549 cells were treated with high glucose (HG).
- Cell viability was assessed using Cell Counting Kit-8 and lactate dehydrogenase assays.
- Inflammatory markers (IL-6, TNF-α) were measured by ELISA.
- Protein levels of SOCS3, JAK2, STAT3, p-JAK2, and p-STAT3 were analyzed via western blot.
- Cells were treated with a JAK2/STAT3 inhibitor (tyrphostin AG490) or subjected to SOCS3 overexpression.
Main Results:
- High glucose significantly decreased cell viability and increased IL-6 and TNF-α levels in A549 cells.
- HG stimulation led to increased protein levels of SOCS3, p-JAK2, and p-STAT3.
- JAK2/STAT3 inhibition or SOCS3 overexpression ameliorated HG-induced cellular damage and inflammation.
- SOCS3 overexpression and JAK2/STAT3 inhibition enhanced cell viability and suppressed inflammatory cytokine levels.
Conclusions:
- The SOCS3/JAK2/STAT3 signaling pathway is involved in high glucose-induced responses in lung cells.
- Overexpression of SOCS3 or inhibition of the JAK2/STAT3 pathway may offer a therapeutic approach to prevent hyperglycemia-induced lung injury, particularly in diabetic conditions.
Related Concept Videos
The JAK-STAT Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
TGF - β Signaling Pathway
